Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Clinical assessment of intraventricular blood transport in patients undergoing cardiac resynchronization therapy.

Rossini L, Martinez-Legazpi P, Benito Y, Del Villar CP, Gonzalez-Mansilla A, Barrio A, Borja MG, Yotti R, Kahn AM, Shadden SC, Fernández-Avilés F, Bermejo J, Del Álamo JC.

Meccanica. 2017 Feb;52(3):563-576. doi: 10.1007/s11012-015-0322-x. Epub 2016 Jan 7.

2.

Data from acellular human heart matrix.

Sánchez PL, Fernández-Santos ME, Espinosa MA, González-Nicolas MA, Acebes JR, Costanza S, Moscoso I, Rodríguez H, García J, Romero J, Kren SM, Bermejo J, Yotti R, Del Villar CP, Sanz-Ruiz R, Elizaga J, Taylor DA, Fernández-Avilés F.

Data Brief. 2016 May 18;8:211-9. doi: 10.1016/j.dib.2016.04.069. eCollection 2016 Sep.

3.

Intraventricular vortex properties in nonischemic dilated cardiomyopathy.

Bermejo J, Benito Y, Alhama M, Yotti R, Martínez-Legazpi P, Del Villar CP, Pérez-David E, González-Mansilla A, Santa-Marta C, Barrio A, Fernández-Avilés F, Del Álamo JC.

Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H718-29. doi: 10.1152/ajpheart.00697.2013. Epub 2014 Jan 10.

4.

Validation of noninvasive indices of global systolic function in patients with normal and abnormal loading conditions: a simultaneous echocardiography pressure-volume catheterization study.

Yotti R, Bermejo J, Benito Y, Sanz-Ruiz R, Ripoll C, Martínez-Legazpi P, del Villar CP, Elízaga J, González-Mansilla A, Barrio A, Bañares R, Fernández-Avilés F.

Circ Cardiovasc Imaging. 2014 Jan;7(1):164-72. doi: 10.1161/CIRCIMAGING.113.000722. Epub 2013 Oct 30.

5.

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, Okhuysen PC, Guerrero NH, Martinez-Sandoval FG, Meléndez-Romero JH, Jiang ZD, Asturias EJ, Halpern J, Torres OR, Hoffman AS, Villar CP, Kassem RN, Flyer DC, Andersen BH, Kazempour K, Breisch SA, Glenn GM.

Lancet. 2008 Jun 14;371(9629):2019-25. doi: 10.1016/S0140-6736(08)60839-9.

PMID:
18554712
6.

Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch.

Frerichs DM, Ellingsworth LR, Frech SA, Flyer DC, Villar CP, Yu J, Glenn GM.

Vaccine. 2008 May 23;26(22):2782-7. doi: 10.1016/j.vaccine.2008.02.070. Epub 2008 Mar 28.

PMID:
18455283
7.

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.

Glenn GM, Villar CP, Flyer DC, Bourgeois AL, McKenzie R, Lavker RM, Frech SA.

Infect Immun. 2007 May;75(5):2163-70. Epub 2007 Jan 29.

8.

Dose sparing with intradermal injection of influenza vaccine.

Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM.

N Engl J Med. 2004 Nov 25;351(22):2295-301. Epub 2004 Nov 3.

9.

Profiling assisted reproductive technology: outcomes and quality of infertility management.

Steinberg EP, Holtz PM, Sullivan EM, Villar CP.

Fertil Steril. 1998 Apr;69(4):617-23. Review.

PMID:
9548148

Supplemental Content

Loading ...
Support Center